April 12, 2021
The US Food and Drug Administration has declared Medtronic’s recall of seven models of defibrillating cardiac rhythm devices, due to a risk for premature battery depletion, […]
April 10, 2021
The US Food and Drug Administration (FDA) on Friday announced its first-ever approval of an artificial intelligence device to help find colon lesions during colonoscopy. The […]
April 9, 2021
The US Food and Drug Administration (FDA) has named Medtronic’s recent worldwide recall of unused Valiant Navion thoracic stent grafts as Class I, the label given to […]
April 9, 2021
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) today recommended that healthcare facilities […]
April 9, 2021
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. In addition to the unusual blood clots linked to the AstraZeneca COVID-19 […]
April 5, 2021
The US Food and Drug Administration (FDA) has approved the nonstimulant medication viloxazine extended-release capsules (Qelbree, Supernus Pharmaceuticals) for the treatment of attention deficit hyperactivity disorder […]
April 1, 2021
The US Food and Drug Administration has approved alirocumab (Praluent, Regeneron Pharmaceuticals) injection as add-on therapy for adults with homozygous familial hypercholesterolemia, the agency announced. The proprotein convertase […]
March 31, 2021
The European Commission has approved the oral targeted therapy pemigatinib (Pemazyre) for the treatment of locally advanced or metastatic cholangiocarcinoma, a rare cancer of the bile […]
March 29, 2021
European Union approval has been recommended for duvelisib (Copiktra) for patients with relapsed/refractory chronic lymphocytic leukemia (CLL) or refractory follicular lymphoma (FL) who have received at […]